. Un-score-d, au moins 24 points est considéré comme normal chez les patients dont le niveau social et culturel est dit "moyen ou supérieur", (au moins 9 ans d'études) et de 21 points chez les sujets d'un niveau social dit "inférieur

C. Gallez, Rapport sur le maladie d'Alzheimer et les maladie apparentées, n°2454. Office parlementaire d'évaluation des politiques de santé, 2005.

G. Biessels, S. Staekenborg, and E. Brunner, Risk of dementia in diabetes mellitus: a systematic review, The Lancet Neurology, vol.5, issue.1, pp.64-74, 2006.
DOI : 10.1016/S1474-4422(05)70284-2

L. Velayudhan, M. Poppe, and N. Archer, Risk of developing dementia in people with diabetes and mild cognitive impairment. The British Journal of Psychiatry, pp.36-40, 0196.

P. Barberger-gateau, J. Dartigues, and L. Letenneur, Four Instrumental Activities of Daily Living Score as a Predictor of One-year Incident Dementia, Age and Ageing, vol.22, issue.6, pp.457-463, 1993.
DOI : 10.1093/ageing/22.6.457

I. Sook-ahn, J. Kim, and S. Kim, Impairment of Instrumental Activities of Daily Living in Patients with Mild Cognitive Impairment, Psychiatry Investigation. septembre, vol.3, issue.6, pp.180-184, 2009.

A. Serrano-pozo, M. Frosch, and E. Masliah, Neuropathological Alterations in Alzheimer Disease, Cold Spring Harbor Perspectives in Medicine, vol.1, issue.1, p.6189, 2011.
DOI : 10.1101/cshperspect.a006189

K. Blennow, M. De-leon, and H. Zetterberg, Alzheimer's disease. Lancet. 29 juillet, pp.387-403, 2006.
URL : https://hal.archives-ouvertes.fr/hal-01098836

R. Mahley, K. Weisgraber, and Y. Huang, Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer's disease, Proceedings of the National Academy of Sciences, pp.5644-51, 2006.
DOI : 10.1073/pnas.0600549103

N. Kota, L. Shankarappa, B. Shivakumar, and P. , Dementia and Diabetes Mellitus: Association with Apolipoprotein E4 Polymorphism from a Hospital in Southern India, International Journal of Alzheimer's Disease, vol.40, issue.3, 2012.
DOI : 10.1373/clinchem.2003.021683

K. Chen, E. Reese, and H. Kim, Disturbed Neurotransmitter Transporter Expression in Alzheimer???s Disease Brain, Journal of Alzheimer's Disease, vol.26, issue.4, pp.755-66, 2011.
DOI : 10.3233/JAD-2011-110002

A. Martorana and G. Koch, Is dopamine involved in Alzheimer's disease? " . Frontiers in Aging Neuroscience, p.252, 2014.

M. Etminan, S. Gill, and A. Samii, Effect of non-steroidal anti-inflammatory drugs on risk of

J. Luchsinger, C. Reitz, and L. Honig, Aggregation of vascular risk factors and risk of incident Alzheimer disease, Neurology, vol.65, issue.4, pp.545-51, 2005.
DOI : 10.1212/01.wnl.0000172914.08967.dc

R. Whitmer, S. Sidney, and J. Selby, Midlife cardiovascular risk factors and risk of dementia in late life, Neurology, vol.64, issue.2, pp.277-81, 2005.
DOI : 10.1212/01.WNL.0000149519.47454.F2

N. Li, A. Lee, and R. Whitmer, Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis, BMJ, vol.340, issue.jan12 1, p.340, 2010.
DOI : 10.1136/bmj.b5465

P. Kehoe and G. Wilcock, Is inhibition of the renin?angiotensin system a new treatment option for Alzheimer's disease? The Lancet Neurology, pp.373-381, 2007.

K. Hall, J. Murrell, and A. Ogunniyi, Cholesterol, APOE genotype, and Alzheimer disease: An epidemiologic study of Nigerian Yoruba, Neurology, vol.66, issue.2, pp.66-223, 2006.
DOI : 10.1212/01.wnl.0000194507.39504.17

A. Newman, A. Fitzpatrick, and O. Lopez, Dementia and Alzheimer's Disease Incidence in Relationship to Cardiovascular Disease in the Cardiovascular Health Study Cohort, Journal of the American Geriatrics Society, vol.52, issue.7, pp.53-1101, 2005.
DOI : 10.1111/j.1532-5415.2005.53360.x

J. De-la-torre, Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. The Lancet Neurology, pp.184-190, 2004.

C. Qiu, B. Winblad, and L. Fratiglioni, The age-dependent relation of blood pressure to cognitive function and dementia. The Lancet Neurology, pp.487-99, 2005.

C. Derouesné, J. Poitreneau, and L. Hugonot, Groupe de recherche sur l'évaluation cognitive (GRECO) Le Mental-State Examination (MMSE): un outil pratique pour l'évaluation de l'état cognitif des patients par le clinicien. Version française consensuelle, Presse médicale, pp.1141-1149, 1999.

M. Benoit, P. Brocker, and J. Clement, Les symptômes psychologiqueset comportementaux de la démence : description et prise en charge. Revue Neurologique, pp.161-357, 2005.
DOI : 10.1016/s0035-3787(05)85064-7

A. Sastre, A. Mcshane, R. Sherriff, and F. , Memantine for dementia. s.l. : Cochrane Dementia and Cognitive Improvement Group, p.3154, 2004.

C. Holmes, D. Boche, and D. Wilkinson, Long-term effects of A??42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial, The Lancet, vol.372, issue.9634, pp.9634-216, 2008.
DOI : 10.1016/S0140-6736(08)61075-2

R. Wilson, P. Scherr, and J. Schneider, Relation of cognitive activity to risk of developing Alzheimer disease, Neurology, vol.69, issue.20, pp.1911-1931, 2007.
DOI : 10.1212/01.wnl.0000271087.67782.cb

N. Lautenschlager, K. Cox, and L. Flicker, Effect of Physical Activity on Cognitive Function in Older Adults at Risk for Alzheimer Disease, JAMA, vol.300, issue.9, pp.300-1027, 2008.
DOI : 10.1001/jama.300.9.1027

R. Riemersma-van-der-lek, D. Swaab, and J. Twisk, Effect of Bright Light and Melatonin on Cognitive and Noncognitive Function in Elderly Residents of Group Care Facilities, JAMA, vol.299, issue.22, pp.299-2642, 2008.
DOI : 10.1001/jama.299.22.2642

K. Sink, K. Holden, and K. Yaffe, Pharmacological Treatment of Neuropsychiatric Symptoms of Dementia, JAMA, vol.293, issue.5
DOI : 10.1001/jama.293.5.596

I. Douglas and S. Smeeth, Exposure to antipsychotics and risk of stroke: self controlled case series study, BMJ, vol.337, issue.aug28 2, 2008.
DOI : 10.1136/bmj.a1227

I. Bourdel-marchasson, A. Tulon, and M. Erpelding, La qualité de vie des diabétiques de type 2 vivant en France métropolitaine: de multiples facteurs associés. Entred, pp.15-20, 2007.

T. Valente, A. Gella, and X. Fernàndez-busquets, Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus, Neurobiology of Disease, vol.37, issue.1, pp.37-67, 2010.
DOI : 10.1016/j.nbd.2009.09.008

M. S. Beeri, J. Schmeidler, and J. M. Silverman, Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology. Neurology. 2 septembre, pp.71-750, 2008.

E. M. Schrijvers, J. C. Witteman, and E. J. Sijbrands, Insulin metabolism and the risk of Alzheimer disease: The Rotterdam Study, Neurology, vol.75, issue.22, pp.1982-1987, 2010.
DOI : 10.1212/WNL.0b013e3181ffe4f6

S. Craft, The role of metabolic disorders in Alzheimer's disease and vascular dementia: two roads converged? Archives of neurology, pp.300-305, 2009.

S. De-la-monte and J. Wands, Alzheimer's Disease is Type 3 Diabetes???Evidence Reviewed, Journal of Diabetes Science and Technology, vol.13, issue.11
DOI : 10.1128/MCB.17.3.1595

A. Penfornis, I. Bourdel-marchasson, and S. Quere, Real-life comparison of DPP4-inhibitors with conventional oral antidiabetics as add-on therapy to metformin in elderly patients with type 2 diabetes: The HYPOCRAS study, Diabetes & Metabolism, vol.38, issue.6, pp.550-557
DOI : 10.1016/j.diabet.2012.08.003

S. Inouye, C. Van-dyck, and C. Alessi, Clarifying Confusion: The Confusion Assessment Method, Annals of Internal Medicine, vol.113, issue.12, pp.1-8, 1990.
DOI : 10.7326/0003-4819-113-12-941

P. Aalten, J. Jolles, M. De-vugt, and F. Verhey, The Influence of neuropsychological functioning on neuropsychiatric problems in dementia. The Journal of Neuropsychiatry & Clinical Neurosciences, pp.50-56, 2007.

. Dementia, A Prospective Cohort Study of 358 Patients. The Journal of clinical psychiatry, pp.584-592, 2009.

C. Dillon, C. Serrano, and D. Castro, Behavioral symptoms related to cognitive impairement, Neuropsychiatric Disease and Treatment, pp.1443-1455, 2013.

B. Mégarbane, L. Donetti, and T. Blanc, Intoxications graves par médicaments et substances illicites en réanimation. ScienceDirect -Réanimation 15, pp.332-342, 2006.

A. Foucrier, A. Yavchitz, and A. Restoux, Syndromes de sevrage en réanimation. Conférence d'actualisation SFAR. Clichy : s.n, pp.243-250, 2006.

C. Druet, C. Roudier, I. Romon, and I. Bourdel-marchasson, Échantillon national témoin représentatif des personnes diabétiques, Entred 2007-2010. Caractéristiques, état de santé, prise en charge et poids économique des personnes diabétiques, 20013.

C. Berr, T. Akbaraly, and F. Nourashemi, L'épidémiologie des démences. La presse medicale, pp.1431-1441, 2007.

M. Benoit, P. Staccini, and P. Brocker, Symptômes comportementaux et psychologiques dans la maladied' Alzheimer : résultats de l'étude REAL.FR. La Revue de médecine interne, pp.319-324, 2003.
DOI : 10.1016/s0248-8663(03)80690-2

A. Alpérovitch, J. Dartigues, and K. Ritchie, L'étude des Trois Cités: relation entre pathologie vasculaire et démence. Revue médicale de l'Assurance Maladie. avril-juin, pp.2-117, 2006.

M. Sjögren, M. Mielke, and D. Gustafson, Cholesterol and Alzheimer's disease -is there a relation? Mechanisms of Ageing and Development, pp.138-185, 2006.

T. Etgen, D. Sander, H. Bickel, and H. Förstl, Mild cognitive impairment and Dementia: The importance of modifiable risk factors. Deutsches Ärzteblatt International, 2011.

C. Annweiler, F. Herrmann, and B. Fantino, Effectiveness of the Combination of Memantine Plus Vitamin D on Cognition in Patients With Alzheimer Disease, Cognitive And Behavioral Neurology, vol.25, issue.3, pp.25-121
DOI : 10.1097/WNN.0b013e31826df647

S. Gillette-guyonnets, F. Nourhashemi, and S. Andrieu, The REAL.FR Research Program on Alzheimer's disease and its management: Methods and preliminary results, The Journal of Nutrition, Healt & Aging, vol.7, issue.2, 2003.

S. Harston, Présentation clinique et pièges diagnostiques de l'épilepsie du sujet âgé

P. Chevalier, Continuer ou arrêter les neuroleptiques chez des patients déments ? www.minerva-ebm.be/fr, 2009.

M. Plastino, A. Fava, and D. Pirritano, Effects of insulinic therapy on cognitive impairment in patients with Alzheimer disease and Diabetes Mellitus type-2, Journal of the Neurological Sciences, vol.288, issue.1-2, pp.112-116, 2010.
DOI : 10.1016/j.jns.2009.09.022

R. Misbin, L. Green, and B. Stadel, Lactic Acidosis in Patients with Diabetes Treated with Metformin, New England Journal of Medicine, vol.338, issue.4, pp.265-271, 1998.
DOI : 10.1056/NEJM199801223380415

R. Stahl and W. Berger, Higher incidence of severe hypoglycaemia leading to hospital admission in Type 2 diabetic patients treated with long-acting versus short-acting sulphonylureas, Diabetic Medicine, vol.116, issue.7, pp.586-90, 1999.
DOI : 10.1016/S0895-4356(97)00024-3

P. Rochon, S. Normand, and T. Gomes, Antipsychotic Therapy and Short-term Serious Events in Older Adults With Dementia. Archives of Internal Medicine, pp.168-1090, 2008.

K. Zint, W. Haefeli, and R. Glynn, Impact of drug interactions, dosage, and duration of therapy on the risk of hip fracture associated with benzodiazepine use in older adults, Pharmacoepidemiology and Drug Safety, vol.53, issue.12, pp.1248-55
DOI : 10.1002/pds.2031

J. Belmin, R. Péquignot, and C. Konrat, Management of Alzheimer disease. La Presse Médicale, pp.10-12, 2007.

J. Wu, M. Haan, and J. Liang, Impact of Antidiabetic Medications on Physical and Cognitive Functioning of Older Mexican Americans with Diabetes Mellitus, Annals of Epidemiology, vol.13, issue.5, pp.369-376, 2003.
DOI : 10.1016/S1047-2797(02)00464-7

H. Curran, R. Collins, and S. Fletcher, Older adults and withdrawal from benzodiazepine hypnotics in general practice: effects on cognitive function, sleep, mood and quality of life, Psychological Medicine, vol.33, issue.7, pp.33-1223, 2003.
DOI : 10.1017/S0033291703008213

L. Volicer, D. Harper, and B. Manning, Sundowning and circadian rhythms in

P. Aisen, L. Schneider, and M. Sano, High dose B vitamin supplementation and cognitive decline in Alzheimer's disease: A randomized controlled trial, Journal of the American Medical Association, vol.15, issue.15, pp.300-1774, 2008.

C. Lin and W. Sheu, Hypoglycaemic episodes and risk of dementia in diabetes mellitus: 7-year follow-up study, Journal of Internal Medicine, vol.108, issue.Suppl. 2, pp.273-102
DOI : 10.1111/joim.12000

P. Crane, R. Walker, and R. Hubbard, Glucose Levels and Risk of Dementia. The New England Journal of Medicin, pp.540-548, 2013.

R. Whitmer, A. Karter, and K. Yaffe, Hypoglycemic Episodes and Risk of Dementia in Older Patients With Type 2 Diabetes Mellitus, JAMA, vol.301, issue.15, pp.1565-1572, 2009.
DOI : 10.1001/jama.2009.460

L. Bäckman, S. Jones, and A. Berger, Multiple cognitive deficits during the transition to

J. Guelfi, L. Article-de, and . Israël, Evaluation de l'autonomie, Les activités instrumentales de la vie quotidienne, IADL. [éd.] Médicales. L'évaluation clinique standardisée en psychiatrie, pp.477-480, 1996.

J. Belmin, Confusion Assessment Method ou CAM, un outil pour le diagnostic de la confusion mentale chez les sujets âgés. La revue de gériatrie, pp.713-715, 2008.

S. Gillette-guyonnet, F. Nourhashemi, and S. Andrieu, The REALFR Research Program on Alzheimer's disease and its management: Methods and Preliminary Results, The Journal of Nutrition Health and Aging, vol.7, p.2, 2003.

C. Vantelon, Les anticholinest??rasiques en??soins de??longue dur??e??: analyse des??pratiques actuelles ????partir d'une????tude observationnelle francoqu??b??coise, La Revue de M??decine Interne, vol.27, issue.8, pp.588-594, 2006.
DOI : 10.1016/j.revmed.2006.04.012

. Gillette-guyonnet, S. Andrieur, and F. Nourhashémi, Présentation de l'étude multicentrique en réseau. Facteurs prédictifs d'hospitalisation et filières de soins chez des patients atteints de la maladie d'Alzheimer (REAL.FR). La revue de médecine interne, pp.24-278, 2003.

H. Ramaroson, C. Helmer, and P. Barberger-gateau, Prévalence de la démence et de la maladie d'Alzheimer chez les personnes de 75 ans et plus : données réactualisées de la cohorte PAQUID, Revue Neurologique, vol.159, pp.4-405

J. Ankri, Épidémiologie des démences et de la maladie d'Alzheimer. Bulletin épidémiologique hebdomadaire (BEH), pp.42-44, 2006.

A. Association and . Diabetes, Standards of medical care in diabetes. Diabetes Care, pp.31-43, 2008.